Comparison of efficacy and toxicity of FC and FCR regimens in primary B-cell chronic lymphocytic leukemia: a retrospective study

Comparison of efficacy and toxicity of FC and FCR regimens in primary B-cell chronic lymphocytic leukemia: a retrospective study

Preclinical studies showed synergic anti-tumor activity of Rituximab and Fludarabin. Comparison of efficacy of FC with FCR regimens administered in first line therapy and their influence on disease-free and overall survival in patients with B-cell lymphocytic leukemia were the main goals of this ret...

Full description

Bibliographic Details
Main Authors: Ye. А. Stadnik, Ye. А. Nikitin, B. V. Biderman, G. N. Salogub, Yu. Yu. Lorie, N. N. Tsyba, Yu. A. Alexeeva, V. A. Doronin, V. N. Mashuk, R. I. Vabishevich, A. L. Melikyan, T. I. Kolosheinova, L. Yu. Kolosova, A. B. Sudarikov, L. G. Kovaleva, A. Yu. Zaritsky
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/679

Internet

https://oncohematology.abvpress.ru/ongm/article/view/679

Similar Items